Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C30H32FNO13.ClH |
| Molecular Weight | 670.033 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC=CC2=C1C(=O)C3=C(C2=O)C(O)=C4C[C@](O)(C[C@H](O[C@@H]5O[C@@H](C)[C@@H](O)[C@@H](O)[C@H]5F)C4=C3O)C(=O)COC(=O)CCN
InChI
InChIKey=PISPJMVXLMWWNB-ZZBYHBTRSA-N
InChI=1S/C30H32FNO13.ClH/c1-11-23(35)28(40)22(31)29(44-11)45-15-9-30(41,16(33)10-43-17(34)6-7-32)8-13-19(15)27(39)21-20(25(13)37)24(36)12-4-3-5-14(42-2)18(12)26(21)38;/h3-5,11,15,22-23,28-29,35,37,39-41H,6-10,32H2,1-2H3;1H/t11-,15-,22+,23+,28-,29-,30-;/m0./s1
GALARUBICIN (DA-125) is an anthracycline derivative with anticancer activity, containing fluorine. The mechanism of action of this drug lies in inhibition of nucleic acid synthesis through intercalation with DNA. Because the structure and DNA-intercalating properties of DA-125 are similar to adriamycin, the cytotoxic effects of the two anthracyclines probably have similar biochemical mechanisms. Preclinical studies suggest that it may have greater activity and less cardiac toxicity than adriamycin. In a rodent study, administration of D-125 in higher dose levels (25 to 50 mg/kg) has been shown to result in testicular damage.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
140637-86-1
Created by
admin on Mon Mar 31 22:09:21 GMT 2025 , Edited by admin on Mon Mar 31 22:09:21 GMT 2025
|
NON-SPECIFIC STOICHIOMETRY | |||
|
114758
Created by
admin on Mon Mar 31 22:09:21 GMT 2025 , Edited by admin on Mon Mar 31 22:09:21 GMT 2025
|
PRIMARY | |||
|
140637-82-7
Created by
admin on Mon Mar 31 22:09:21 GMT 2025 , Edited by admin on Mon Mar 31 22:09:21 GMT 2025
|
PRIMARY | |||
|
C7EKF2I37Q
Created by
admin on Mon Mar 31 22:09:21 GMT 2025 , Edited by admin on Mon Mar 31 22:09:21 GMT 2025
|
PRIMARY | |||
|
DTXSID30161451
Created by
admin on Mon Mar 31 22:09:21 GMT 2025 , Edited by admin on Mon Mar 31 22:09:21 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD